YIFAN PHARMACEUTICAL CO (SZSE:002019) Operating Cash Flow per Share : ¥0.43 (TTM As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Operating Cash Flow per Share?

YIFAN PHARMACEUTICAL CO's operating cash flow per share for the three months ended in Mar. 2024 was ¥0.15. YIFAN PHARMACEUTICAL CO's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.43.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of YIFAN PHARMACEUTICAL CO was 6.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -31.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -24.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for YIFAN PHARMACEUTICAL CO's Operating Cash Flow per Share or its related term are showing as below:

SZSE:002019' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -36.4 Med: 26.85 Max: 131
Current: -31.9

During the past 13 years, YIFAN PHARMACEUTICAL CO's highest 3-Year average Operating Cash Flow per Share Growth Rate was 131.00% per year. The lowest was -36.40% per year. And the median was 26.85% per year.

SZSE:002019's 3-Year OCF Growth Rate is ranked worse than
88.34% of 806 companies
in the Drug Manufacturers industry
Industry Median: 6.9 vs SZSE:002019: -31.90

YIFAN PHARMACEUTICAL CO Operating Cash Flow per Share Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Operating Cash Flow per Share Chart

YIFAN PHARMACEUTICAL CO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.77

0.90

0.25

0.37

0.29

YIFAN PHARMACEUTICAL CO Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	0.13	0.08	0.07	0.15

Competitive Comparison of YIFAN PHARMACEUTICAL CO's Operating Cash Flow per Share

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's Price-to-Operating-Cash-Flow falls into.

YIFAN PHARMACEUTICAL CO Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

YIFAN PHARMACEUTICAL CO's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	348.585	/	1224.607
	=	0.28

YIFAN PHARMACEUTICAL CO's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	180.84	/	1216.479
	=	0.15

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.43

YIFAN PHARMACEUTICAL CO Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300

Website

https://en.yifanyy.com

YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines